Advanced Glycation End Products in Disease Development and Potential Interventions

Area of Science:

• Biochemistry and Molecular Biology
• Pathophysiology
• Gerontology

Background:

• Advanced glycation end products (AGEs) are formed via non-enzymatic sugar reactions with proteins, lipids, or nucleic acids.
• AGEs accumulate in tissues, originating endogenously or from diet and smoking.
• AGEs are implicated in numerous health conditions, including diabetes, cardiovascular disease, and neurodegeneration.

Purpose of the Study:

• To review major diseases linked to AGE accumulation.
• To present clinical and experimental evidence on AGE-related pathologies.
• To discuss intervention strategies for AGE-related diseases.

Main Methods:

• Review of clinical and animal studies on AGE accumulation and associated diseases.
• Analysis of common pathogenic mechanisms of AGEs across different organs.
• Summary of current intervention strategies targeting AGE formation and intake.

Main Results:

• AGE accumulation is associated with diabetes complications, cardiovascular disease, and neurodegeneration.
• Common pathogenic mechanisms include oxidative stress, chronic inflammation, and protein cross-linking.
• Interventions focus on inhibiting AGE formation (antioxidants) and reducing dietary intake.

Conclusions:

• AGEs are significant risk factors accelerating aging and impacting health, especially in hyperglycemia.
• Monitoring AGE levels and adopting nutritional interventions are key for health maintenance.
• Lifestyle modifications and dietary changes can reduce the risk of AGE-related complications.